Anika Therapeutics | ANIK - الدائنين التجاريين

سعر السهم
15.40
التغيير اليومي
0.10 0.65%
شهريا
7.24%
سنويا
14.33%
Q2 التوقعات
14.36




الدائنين التجاريين تغيير تاريخ
Abbott USD 4.12B 183M 2025-09
Agenus USD 82.99M 2.3M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Anika Therapeutics USD 6.04M 1.31M 2025-12
Arrowhead Research USD 32.94M 15.26M 2025-12
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Insmed USD 79.91M 316K 2025-12
Integra LifeSciences USD 95.73M 3.42M 2025-12
Intrexon USD 4.85M 3.12M 2024-06
J&J USD 11.99B 2.37B 2025-12
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Merit Medical Systems USD 60.55M 4.19M 2025-12
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 927M 2025-12
Smith & Nephew USD 1.19B 73M 2025-12
Stryker USD 1.5B 56M 2025-09
Surmodics USD 5.93M 3.14M 2025-06
Veracyte USD 4.59M 916K 2025-12
Xencor USD 10.83M 1.75M 2025-12
Zimmer Biomet Holdings USD 303M 12.3M 2025-12